Home

לסירוגין דיילת להתחמק dp dr kappa antagonist טיל פופולרי שעועית ירוקה

Anti-HLA-DP antibody [B7/21] (ab20897) | Abcam
Anti-HLA-DP antibody [B7/21] (ab20897) | Abcam

Molecular mechanism of biased signaling at the kappa opioid receptor |  Nature Communications
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications

Frontiers | Modulation of Morphine Analgesia, Antinociceptive Tolerance,  and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist  O-1966
Frontiers | Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

Development of κ Opioid Receptor Antagonists | Journal of Medicinal  Chemistry
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic  Agents: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry

Conformational Constraint between Aromatic Residue Side Chains in the  “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis  Results in a Potent and Selective Kappa Opioid Receptor Antagonist |  Journal of
Conformational Constraint between Aromatic Residue Side Chains in the “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist | Journal of

Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist  Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical  Neuroscience
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience

Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) | Abcam
Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) | Abcam

Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan  To Possess Highly Potent and Selective Opioid δ Receptor Antagonist  Activity | Journal of Medicinal Chemistry
Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan To Possess Highly Potent and Selective Opioid δ Receptor Antagonist Activity | Journal of Medicinal Chemistry

Nanobody-enabled monitoring of kappa opioid receptor states | Nature  Communications
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications

HLA DQ/DR/DP Antibody (rHLA-Pan/3475) (NBP3-07808): Novus Biologicals
HLA DQ/DR/DP Antibody (rHLA-Pan/3475) (NBP3-07808): Novus Biologicals

Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on  Live Cells | JACS Au
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells | JACS Au

Antagonists of the kappa opioid receptor - ScienceDirect
Antagonists of the kappa opioid receptor - ScienceDirect

G protein-coupled receptor signaling: transducers and effectors | American  Journal of Physiology-Cell Physiology
G protein-coupled receptor signaling: transducers and effectors | American Journal of Physiology-Cell Physiology

Delta Opiate Receptor Antagonist - an overview | ScienceDirect Topics
Delta Opiate Receptor Antagonist - an overview | ScienceDirect Topics

Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the  Brain
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

Frontiers | The role of endogenous opioid neuropeptides in  neurostimulation-driven analgesia
Frontiers | The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in  Compulsive Behaviors
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors

Angiotensin‐converting enzymes as druggable features of psychiatric and  neurodegenerative disorders - Santiago - Journal of Neurochemistry - Wiley  Online Library
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders - Santiago - Journal of Neurochemistry - Wiley Online Library

Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist,  Enhances the Diuretic Response and Limits Electrolyte Losses to  Standard-of-Care Diuretics | Hypertension
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension

Role of RGS12 in the differential regulation of kappa opioid  receptor-dependent signaling and behavior | Neuropsychopharmacology
Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology

Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced  Adverse Effects: A Review
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review

Early life stress dysregulates kappa opioid receptor signaling within the  lateral habenula - ScienceDirect
Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula - ScienceDirect

Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent  developments and future therapeutic strategies - Khan - 2021 - Pharmacology  Research & Perspectives - Wiley Online Library
Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent developments and future therapeutic strategies - Khan - 2021 - Pharmacology Research & Perspectives - Wiley Online Library

Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting  | Pharmacological Reviews
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting | Pharmacological Reviews

Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal  Treatment Potential of Buprenorphine
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine

The blocking of kappa‐opioid receptor reverses the changes in dorsolateral  striatum dopamine dynamics during the amphetamine sensitization - Azocar -  2019 - Journal of Neurochemistry - Wiley Online Library
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library

Molecules | Free Full-Text | Kappa Opioid Receptor Agonist Mesyl Sal B  Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive  Side-Effects than Salvinorin A in Rodents
Molecules | Free Full-Text | Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents